Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prognostic Effect of Bedtime Losartan in Nondialysis CKD
NCT03604003Unknown
- Sponsor
- The Fifth Affiliated Hospital of Sun Yat-sen University
- Start
- Nov 2018
- Primary completion
- Jun 2021
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of losartan in chronic kidney disease (CKD) and hypertension (HTN) (2 arms), sponsored by The Fifth Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Renal events and Cardiovascular events at 5 years. Status: unknown.
02
Drugs
losartan
03
Conditions
chronic kidney disease (CKD)hypertension (HTN)
Beyond the preview
Go deeper on NCT03604003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03604003.